Eur Respir J:炎症和感染对早期囊性纤维化患者结构性肺病的累积效应

2019-07-12 xing.T MedSci原创

由此可见,监测BAL中的肺部炎症对结构性肺病程度有累积影响,并且比感染更多。这为旨在减少幼儿炎症的疗法提供了强有力的理论依据。

肺部炎症和感染是囊性纤维化(CF)肺病患者重要的临床和预后标志物。然而,在幼儿中,无论它们对呼吸系统健康产生是短暂的效应还是累积的长期影响,这在很大程度上是未知的。近日,呼吸疾病领域权威杂志Eur Respir J上发表了一篇研究文章,研究人员的目的是明确对它们进行重复检测是否对结构性肺病有害。 

所有年龄<6岁的患者均进行年度计算机断层扫描(CT)检查和支气管肺泡灌洗(BAL)。研究人员使用PRAGMA-CF方法测定CT上的结构性肺病,并计算在BAL中检测到游离中性粒细胞弹性蛋白酶(NE)和感染的次数,以确定累积的BAL史。考虑到重复随访和年龄调整,线性混合模型分析用于明确相关性。

该研究纳入了265名儿童(683次扫描结果)进行分析,1161次就诊进行了BAL。疾病与先前NE的数量显著相关(0.31,95%CI为0.09-0.54; p=0.007),但未检测到与感染相关(0.23,95%CI为-0.01-0.47; p=0.060)。

由此可见,监测BAL中的肺部炎症对结构性肺病程度有累积效应,并且比感染更多。这为旨在减少幼儿炎症的疗法提供了强有力的理论依据。 

原始出处:

Tim Rosenow.The cumulative effect of inflammation and infection on structural lung disease in early cystic fibrosis.Eur Respir J.2019.https://erj.ersjournals.com/content/54/1/1801771

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1804426, encodeId=254d1804426ce, content=<a href='/topic/show?id=c754e7083a8' target=_blank style='color:#2F92EE;'>#累积效应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77083, encryptionId=c754e7083a8, topicName=累积效应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Mon May 04 04:38:00 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805729, encodeId=674a1805e2980, content=<a href='/topic/show?id=0628e859942' target=_blank style='color:#2F92EE;'>#结构性肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78599, encryptionId=0628e859942, topicName=结构性肺病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Wed Jul 24 17:38:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671931, encodeId=b1af16e1931d0, content=<a href='/topic/show?id=58378220131' target=_blank style='color:#2F92EE;'>#肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82201, encryptionId=58378220131, topicName=肺病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f0826868454, createdName=amy0559, createdTime=Wed Jan 22 09:38:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006171, encodeId=a75c20061e192, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40381, encryptionId=a5c54038142, topicName=囊性纤维化患者)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/17F844FBE270B8196CB4C53EC9493C57/100, createdBy=9d712500079, createdName=ms5906905816781247, createdTime=Wed Nov 06 00:38:00 CST 2019, time=2019-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805689, encodeId=904b1805689d1, content=<a href='/topic/show?id=95eae859563' target=_blank style='color:#2F92EE;'>#结构性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78595, encryptionId=95eae859563, topicName=结构性)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Aug 04 20:38:00 CST 2019, time=2019-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675907, encodeId=ddaf16e5907d8, content=<a href='/topic/show?id=7395403e580' target=_blank style='color:#2F92EE;'>#囊性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40375, encryptionId=7395403e580, topicName=囊性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=926927300775, createdName=wolongzxh, createdTime=Sat Feb 22 00:38:00 CST 2020, time=2020-02-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1804426, encodeId=254d1804426ce, content=<a href='/topic/show?id=c754e7083a8' target=_blank style='color:#2F92EE;'>#累积效应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77083, encryptionId=c754e7083a8, topicName=累积效应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Mon May 04 04:38:00 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805729, encodeId=674a1805e2980, content=<a href='/topic/show?id=0628e859942' target=_blank style='color:#2F92EE;'>#结构性肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78599, encryptionId=0628e859942, topicName=结构性肺病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Wed Jul 24 17:38:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671931, encodeId=b1af16e1931d0, content=<a href='/topic/show?id=58378220131' target=_blank style='color:#2F92EE;'>#肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82201, encryptionId=58378220131, topicName=肺病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f0826868454, createdName=amy0559, createdTime=Wed Jan 22 09:38:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006171, encodeId=a75c20061e192, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40381, encryptionId=a5c54038142, topicName=囊性纤维化患者)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/17F844FBE270B8196CB4C53EC9493C57/100, createdBy=9d712500079, createdName=ms5906905816781247, createdTime=Wed Nov 06 00:38:00 CST 2019, time=2019-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805689, encodeId=904b1805689d1, content=<a href='/topic/show?id=95eae859563' target=_blank style='color:#2F92EE;'>#结构性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78595, encryptionId=95eae859563, topicName=结构性)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Aug 04 20:38:00 CST 2019, time=2019-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675907, encodeId=ddaf16e5907d8, content=<a href='/topic/show?id=7395403e580' target=_blank style='color:#2F92EE;'>#囊性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40375, encryptionId=7395403e580, topicName=囊性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=926927300775, createdName=wolongzxh, createdTime=Sat Feb 22 00:38:00 CST 2020, time=2020-02-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1804426, encodeId=254d1804426ce, content=<a href='/topic/show?id=c754e7083a8' target=_blank style='color:#2F92EE;'>#累积效应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77083, encryptionId=c754e7083a8, topicName=累积效应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Mon May 04 04:38:00 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805729, encodeId=674a1805e2980, content=<a href='/topic/show?id=0628e859942' target=_blank style='color:#2F92EE;'>#结构性肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78599, encryptionId=0628e859942, topicName=结构性肺病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Wed Jul 24 17:38:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671931, encodeId=b1af16e1931d0, content=<a href='/topic/show?id=58378220131' target=_blank style='color:#2F92EE;'>#肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82201, encryptionId=58378220131, topicName=肺病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f0826868454, createdName=amy0559, createdTime=Wed Jan 22 09:38:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006171, encodeId=a75c20061e192, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40381, encryptionId=a5c54038142, topicName=囊性纤维化患者)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/17F844FBE270B8196CB4C53EC9493C57/100, createdBy=9d712500079, createdName=ms5906905816781247, createdTime=Wed Nov 06 00:38:00 CST 2019, time=2019-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805689, encodeId=904b1805689d1, content=<a href='/topic/show?id=95eae859563' target=_blank style='color:#2F92EE;'>#结构性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78595, encryptionId=95eae859563, topicName=结构性)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Aug 04 20:38:00 CST 2019, time=2019-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675907, encodeId=ddaf16e5907d8, content=<a href='/topic/show?id=7395403e580' target=_blank style='color:#2F92EE;'>#囊性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40375, encryptionId=7395403e580, topicName=囊性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=926927300775, createdName=wolongzxh, createdTime=Sat Feb 22 00:38:00 CST 2020, time=2020-02-22, status=1, ipAttribution=)]
    2020-01-22 amy0559
  4. [GetPortalCommentsPageByObjectIdResponse(id=1804426, encodeId=254d1804426ce, content=<a href='/topic/show?id=c754e7083a8' target=_blank style='color:#2F92EE;'>#累积效应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77083, encryptionId=c754e7083a8, topicName=累积效应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Mon May 04 04:38:00 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805729, encodeId=674a1805e2980, content=<a href='/topic/show?id=0628e859942' target=_blank style='color:#2F92EE;'>#结构性肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78599, encryptionId=0628e859942, topicName=结构性肺病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Wed Jul 24 17:38:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671931, encodeId=b1af16e1931d0, content=<a href='/topic/show?id=58378220131' target=_blank style='color:#2F92EE;'>#肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82201, encryptionId=58378220131, topicName=肺病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f0826868454, createdName=amy0559, createdTime=Wed Jan 22 09:38:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006171, encodeId=a75c20061e192, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40381, encryptionId=a5c54038142, topicName=囊性纤维化患者)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/17F844FBE270B8196CB4C53EC9493C57/100, createdBy=9d712500079, createdName=ms5906905816781247, createdTime=Wed Nov 06 00:38:00 CST 2019, time=2019-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805689, encodeId=904b1805689d1, content=<a href='/topic/show?id=95eae859563' target=_blank style='color:#2F92EE;'>#结构性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78595, encryptionId=95eae859563, topicName=结构性)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Aug 04 20:38:00 CST 2019, time=2019-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675907, encodeId=ddaf16e5907d8, content=<a href='/topic/show?id=7395403e580' target=_blank style='color:#2F92EE;'>#囊性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40375, encryptionId=7395403e580, topicName=囊性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=926927300775, createdName=wolongzxh, createdTime=Sat Feb 22 00:38:00 CST 2020, time=2020-02-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1804426, encodeId=254d1804426ce, content=<a href='/topic/show?id=c754e7083a8' target=_blank style='color:#2F92EE;'>#累积效应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77083, encryptionId=c754e7083a8, topicName=累积效应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Mon May 04 04:38:00 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805729, encodeId=674a1805e2980, content=<a href='/topic/show?id=0628e859942' target=_blank style='color:#2F92EE;'>#结构性肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78599, encryptionId=0628e859942, topicName=结构性肺病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Wed Jul 24 17:38:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671931, encodeId=b1af16e1931d0, content=<a href='/topic/show?id=58378220131' target=_blank style='color:#2F92EE;'>#肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82201, encryptionId=58378220131, topicName=肺病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f0826868454, createdName=amy0559, createdTime=Wed Jan 22 09:38:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006171, encodeId=a75c20061e192, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40381, encryptionId=a5c54038142, topicName=囊性纤维化患者)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/17F844FBE270B8196CB4C53EC9493C57/100, createdBy=9d712500079, createdName=ms5906905816781247, createdTime=Wed Nov 06 00:38:00 CST 2019, time=2019-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805689, encodeId=904b1805689d1, content=<a href='/topic/show?id=95eae859563' target=_blank style='color:#2F92EE;'>#结构性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78595, encryptionId=95eae859563, topicName=结构性)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Aug 04 20:38:00 CST 2019, time=2019-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675907, encodeId=ddaf16e5907d8, content=<a href='/topic/show?id=7395403e580' target=_blank style='color:#2F92EE;'>#囊性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40375, encryptionId=7395403e580, topicName=囊性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=926927300775, createdName=wolongzxh, createdTime=Sat Feb 22 00:38:00 CST 2020, time=2020-02-22, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1804426, encodeId=254d1804426ce, content=<a href='/topic/show?id=c754e7083a8' target=_blank style='color:#2F92EE;'>#累积效应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77083, encryptionId=c754e7083a8, topicName=累积效应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Mon May 04 04:38:00 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805729, encodeId=674a1805e2980, content=<a href='/topic/show?id=0628e859942' target=_blank style='color:#2F92EE;'>#结构性肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78599, encryptionId=0628e859942, topicName=结构性肺病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Wed Jul 24 17:38:00 CST 2019, time=2019-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671931, encodeId=b1af16e1931d0, content=<a href='/topic/show?id=58378220131' target=_blank style='color:#2F92EE;'>#肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82201, encryptionId=58378220131, topicName=肺病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f0826868454, createdName=amy0559, createdTime=Wed Jan 22 09:38:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006171, encodeId=a75c20061e192, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40381, encryptionId=a5c54038142, topicName=囊性纤维化患者)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/17F844FBE270B8196CB4C53EC9493C57/100, createdBy=9d712500079, createdName=ms5906905816781247, createdTime=Wed Nov 06 00:38:00 CST 2019, time=2019-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805689, encodeId=904b1805689d1, content=<a href='/topic/show?id=95eae859563' target=_blank style='color:#2F92EE;'>#结构性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78595, encryptionId=95eae859563, topicName=结构性)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Aug 04 20:38:00 CST 2019, time=2019-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675907, encodeId=ddaf16e5907d8, content=<a href='/topic/show?id=7395403e580' target=_blank style='color:#2F92EE;'>#囊性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40375, encryptionId=7395403e580, topicName=囊性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=926927300775, createdName=wolongzxh, createdTime=Sat Feb 22 00:38:00 CST 2020, time=2020-02-22, status=1, ipAttribution=)]
    2020-02-22 wolongzxh

相关资讯

Nature:突破癌症免疫疗法限制:一种重编程新方法带来希望

“许多肿瘤患者对免疫疗法没有反应,因为这些患者缺乏预先存在的炎症”

Blood:纤溶酶介导的纤维蛋白降解可促进巨噬细胞向炎症部位迁移

巨噬细胞向炎症部位的有效迁移需要细胞表面结合纤溶酶(ogen)。现研究人员对两种模型(巯基乙酸诱导的腹膜炎小鼠及体外巨噬细胞迁移)的纤溶酶(ogen)介导的巨噬细胞迁移缺陷的潜在机制进行研究。

JACC:残余炎症可增加PCI术后患者不良心脑血管事件风险

目前,对于残余炎症风险(RIR)对接受冠脉介入治疗(PCI)且基线低密度脂蛋白胆固醇(LDL-C)≤70mg/dl患者的影响尚不清楚。本研究的目的旨在评估PCI术后高RIR的发生率和影响。本研究纳入了2009-2016年基线LDL-C≤70mg/dl并进行了高敏C反应蛋白(hsCRP)评估的PCI患者,高RIR定义为hsCRP >2 mg/l。患者根据RIR状态分为持续性低RIR组、RIR减

PNAS:新型糖皮质激素受体调节剂具有良好体内抗炎活性

已有的研究显示,非甾体化合物CpdX,最初在20年前被确定为可能的孕激素,不久之后,其被作为治疗炎症性疾病的可能药物,选择性地触发NFκB/ AP1介导的糖皮质激素受体的间接反式阻断功能。因此,其可能是一个选择性糖皮质激素受体激动剂调节剂(SEGRAM)。

J Endod:沉默C1减弱牙髓疾病中的炎症和牙槽骨吸收

牙髓疾病是全球慢性感染性疾病中流行性最高的一种,在牙髓感染和发炎时发生,导致根周骨损伤、严重疼痛以及牙齿缺失。尽管有许多研究试图研发有效的治疗方案以减缓骨侵蚀和牙髓疾病相关的炎症,但是目前还是迫切需要行之有效的疗法。

Nat Microbiol:与炎症性肠病和抑郁症有关的肠型

比利时VIB-KU Leuven微生物学中心教授Jeroen Raes于2012年成立了Flemish Gut Flora计划,旨在确定健康相关肠道微生物群的普遍界限,对3000多名健康志愿者的粪便样本进行了测序。最近,他们在《Nature Microbiology》发表文章,描述了缺乏某些抗炎细菌的B2肠型在多诊断中的高患病率研究。